MedPath
NMPA Approval

Azelastine Hydrochloride Eye Drops

国药准字H20244119

June 25, 2024

Drug Information

盐酸氮䓬斯汀滴眼液

眼用制剂

0.05%(6ml:3mg)

化学药品

June 25, 2024

Company Information

Applicant Company

武汉市东湖新技术开发区高新大道858号生物医药园A7展示中心

Manufacturing Company

合肥市高新区科学大道80号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸氮䓬斯汀滴眼液 - NMPA 批准文号 | MedPath